683 Capital Management »

Emergent BioSolutions shares owned by 683 Capital Management

Quarter-by-quarter ownership of Emergent BioSolutions (EBS) shares owned by 683 Capital Management from 13F filings

Historical chart of 683 Capital Management investment in Emergent BioSolutions

Tip: Access up to 7 years of quarterly data

All positions including Emergent BioSolutions held by 683 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Emergent BioSolutions by 683 Capital Management

Quarter filed Position value Share count Share price at filing
2024-12-31 $886k 93k 9.56

More positions owned by 683 Capital Management

Palantir Technologies Cl A Put Option (PLTR)
Eli Lilly & Co. (LLY)
Tesla Motors Put Option (TSLA)
Capital One Financial (COF)
Madrigal Pharmaceuticals Put Option (MDGL)
Uniqure Nv SHS (QURE)
Alnylam Pharmaceuticals Put Option (ALNY)
Carvana Cl A (CVNA)
Insmed Com Par $.01 Put Option (INSM)
Uwm Holdings Corporation Com Cl A (UWMC)
Strategy Cl A New Put Option (MSTR)
Gxo Logistics Incorporated Common Stock (GXO)
Western Digital (WDC)
Novo-nordisk A S Adr Put Option (NVO)
United Therapeutics Corporation Put Option (UTHR)

View all positions for 683 Capital Management

Top funds holding Emergent BioSolutions

BlackRock
Oak Hill Advisors
Vanguard Group
State Street Corporation
American Century Companies
Dimensional Fund Advisors
Palisade Capital Management
Charles Schwab Investment Management
Geode Capital Management
Acadian Asset Management
Connor, Clark & Lunn Investment Management
Marshall Wace
LSV Asset Management
Prescott Group Capital Management
Morgan Stanley

View all funds holding Emergent BioSolutions